Despite these encouraging results, TGFβ’s context-dependent role, as both tumor suppressor and promoter, complicates therapeutic targeting and may lead to unpredictable effects depending on disease stage and tumor microenvironment. The gene discussed is TGFB1; the disease is neoplasm.